Search Results - Hoschen, Kornelia

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Cebranopadol: A Novel, First-in-Class, Strong Analgesic: Results from a Randomized Phase IIa Clinical Trial in Postoperative Acute Pain

    Cebranopadol: A Novel, First-in-Class, Strong Analgesic: Results from a Randomized Phase IIa Clinical Trial in Postoperative Acute Pain by Scholz, Andrea, Bothmer, John, Kok, Maurits, Hoschen, Kornelia, Daniels, Stephen

    Published in Pain physician
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Safety data and beneficial effects of the combined oral contraceptive ethinylestradiol 0.03 mg/chlormadinone acetate 2mg : a 13-cycle, observational study in routine clinical practice

    Safety data and beneficial effects of the combined oral contraceptive ethinylestradiol 0.03 mg/chlormadinone acetate 2mg : a 13-cycle, observational study in routine clinical pract... by Pushparajah, Daphnee S, Rohm, Petra, Hoschen, Kornelia, Alters, Dagmar, Nowack, Christina

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial

    Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial by Plewig, Gerd, Cunliffe, William J, Binder, Natascha, Höschen, Kornelia

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables

    An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lip... by Winkler, Ulrich H, Röhm, Petra, Höschen, Kornelia

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen

    Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen by Brucker, Cosima, Hedon, Bernard, The, Hok Sien, Höschen, Kornelia, Binder, Natascha, Christoph, Annette

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six cycles

    Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six... by Rabe, Thomas, Hartschuh, Elena, Wahlstrom, Torsten, Höschen, Kornelia, König, Simone

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Safety Data and Beneficial Effects of the Combined Oral Contraceptive Ethinylestradiol 0.03 mg/Chlormadinone Acetate 2 mg (Belara®): A 13-Cycle Observational Study in Routine Clinical Practice

    Safety Data and Beneficial Effects of the Combined Oral Contraceptive Ethinylestradiol 0.03 mg/Chlormadinone Acetate 2 mg (Belara®): A 13-Cycle Observational Study in Routine Clini... by Pushparajah, Daphnee S., Röhm, Petra, Höschen, Kornelia, Albers, Dagmar, Nowack, Christina

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  8. 8
    Safety Data and Beneficial Effects of the Combined Oral Contraceptive Ethinylestradiol 0.03 mg/Chlormadinone Acetate 2 mg (Belara[superscript] ?[/superscript] )

    Safety Data and Beneficial Effects of the Combined Oral Contraceptive Ethinylestradiol 0.03 mg/Chlormadinone Acetate 2 mg (Belara[superscript] ?[/superscript] ) by Pushparajah, Daphnee S, Röhm, Petra, Höschen, Kornelia, Albers, Dagmar, Nowack, Christina

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: